ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182) (S.1734)) Issues related to reauthorization of the Prescription Drug User Fee Act (no specific bills) Issues related to drug shortages (Preserving Access to Life-Saving Medications Act of 2011 (H.R.2245) and Preserving Access to Life-Saving Medications Act (S.296) ); Drug Shortages Prevention Act of 2012 (H.R. 3839))
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RYAN AMBROSE | House Committee on Energy & Commerce, Clerk |
| MARY LACEY REUTHER | — |
| MICHAEL RUGGIERO | — |
Medicare/Medicaid MMM
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to the debt ceiling negotiations and Medicare Part D rebates (no specific bills).
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RYAN AMBROSE | House Committee on Energy & Commerce, Clerk |
| MARY LACEY REUTHER | — |
| MICHAEL RUGGIERO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.